American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Netflix
NFLX
|
+$348M |
| 2 |
Booking.com
BKNG
|
+$293M |
| 3 |
TSMC
TSM
|
+$239M |
| 4 |
Howmet Aerospace
HWM
|
+$231M |
| 5 |
Royal Caribbean
RCL
|
+$212M |
Top Sells
| 1 |
Apple
AAPL
|
+$570M |
| 2 |
Palantir
PLTR
|
+$375M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$235M |
| 4 |
Progressive
PGR
|
+$222M |
| 5 |
Salesforce
CRM
|
+$205M |
Sector Composition
| 1 | Technology | 26.45% |
| 2 | Financials | 14.55% |
| 3 | Consumer Discretionary | 12.69% |
| 4 | Industrials | 10.04% |
| 5 | Healthcare | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Quad
QUAD
$333M
| $400K | ﹤0.01% |
70,767
+2,558
| +4% | +$14.5K |
|
2552
Liberty Latin America Class A
LILA
$1.5B
| $399K | ﹤0.01% |
65,388
+1,361
| +2% | +$8.3K |
|
2553
Playtika
PLTK
$1.41B
| $399K | ﹤0.01% |
84,281
+1,914
| +2% | +$9.05K |
|
2554
American Express Global Business Travel
GBTG
$4.32B
| $396K | ﹤0.01% |
62,889
+202
| +0.3% | +$1.27K |
|
2555
N-able
NABL
$1.54B
| $396K | ﹤0.01% |
+48,871
| New | +$396K |
|
2556
Zymeworks
ZYME
$1.19B
| $391K | ﹤0.01% |
31,147
| – | – |
|
2557
AbCellera Biologics
ABCL
$1.34B
| $390K | ﹤0.01% |
113,760
-2,904
| -2% | -$9.96K |
|
2558
Crawford & Co Class B
CRD.B
$494M
| $386K | ﹤0.01% |
36,963
| – | – |
|
2559
Lufax Holding
LU
$2.61B
| $381K | ﹤0.01% |
136,608
+2,220
| +2% | +$6.19K |
|
2560
Mistras Group
MG
$299M
| $380K | ﹤0.01% |
47,498
+9,312
| +24% | +$74.6K |
|
|
BDN
2561
Brandywine Realty Trust
BDN
$789M
| $379K | ﹤0.01% |
88,406
| – | – |
|
2562
SkyWater Technology
SKYT
$509M
| $377K | ﹤0.01% |
+38,343
| New | +$377K |
|
2563
ARS Pharmaceuticals
SPRY
$991M
| $368K | ﹤0.01% |
21,114
-71,532
| -77% | -$1.25M |
|
2564
Braskem
BAK
$1.33B
| $368K | ﹤0.01% |
112,321
+2,286
| +2% | +$7.5K |
|
2565
Tyler Technologies
TYL
$23.6B
| $368K | ﹤0.01% |
621
+69
| +13% | +$40.9K |
|
2566
Ultragenyx Pharmaceutical
RARE
$2.92B
| $366K | ﹤0.01% |
+10,054
| New | +$366K |
|
2567
Liberty Media Series A
FWONA
$22.5B
| $365K | ﹤0.01% |
3,845
+968
| +34% | +$91.9K |
|
2568
FVCBankcorp
FVCB
$240M
| $364K | ﹤0.01% |
30,886
| – | – |
|
2569
Prothena Corp
PRTA
$442M
| $364K | ﹤0.01% |
59,965
+25,129
| +72% | +$153K |
|
2570
Evolv Technologies
EVLV
$1.51B
| $363K | ﹤0.01% |
58,095
-5,220
| -8% | -$32.6K |
|
2571
Farmers & Merchants Bancorp
FMAO
$357M
| $362K | ﹤0.01% |
14,331
-174
| -1% | -$4.4K |
|
2572
Telos
TLS
$490M
| $355K | ﹤0.01% |
112,106
+3,889
| +4% | +$12.3K |
|
2573
Columbus McKinnon
CMCO
$415M
| $355K | ﹤0.01% |
23,235
+157
| +0.7% | +$2.4K |
|
2574
IonQ
IONQ
$16.6B
| $352K | ﹤0.01% |
+8,185
| New | +$352K |
|
2575
CoreCivic
CXW
$2.26B
| $349K | ﹤0.01% |
16,543
-9,628
| -37% | -$203K |
|